Other

OCI cash flow hedges

Vertex Pharmaceuticals OCI cash flow hedges increased by 117.5% to $33.50M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 153.2%, from -$63.00M to $33.50M.

Analysis

StatementIncome Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ1 2015
Last reportedQ3 2025

How to read this metric

Fluctuations reflect changes in the market value of hedging instruments relative to the underlying risk exposure.

Detailed definition

This metric tracks the total unrealized gains and losses on derivative instruments designated as cash flow hedges, net o...

Peer comparison

Used by companies with significant exposure to market price or currency fluctuations.

Metric ID: is_jpm_oci_cash_flow_hedges

Historical Data

8 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q2 '24Q3 '24Q2 '25Q3 '25
Value-$12.73M-$12.73M-$12.73M-$12.73M$11.80M-$63.00M-$191.90M$33.50M
QoQ Change+0.0%+0.0%+0.0%+192.7%-633.9%-204.6%+117.5%
YoY Change+192.7%-395.1%<-999%+153.2%
Range-$191.90M$33.50M
CAGR+73.9%
Avg YoY Growth-443.9%
Median YoY Growth-121.0%

OCI cash flow hedges at Other Companies

Frequently Asked Questions

What is Vertex Pharmaceuticals's oci cash flow hedges?
Vertex Pharmaceuticals (VRTX) reported oci cash flow hedges of $33.50M in Q3 2025.
How has Vertex Pharmaceuticals's oci cash flow hedges changed year-over-year?
Vertex Pharmaceuticals's oci cash flow hedges increased by 153.2% year-over-year, from -$63.00M to $33.50M.
What does oci cash flow hedges mean?
The net change in value of derivatives used to protect against cash flow volatility.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.